Estefania Bolanos

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Correction to: Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders.

Correction to: Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders.

Journal: Journal of clinical immunology

Published: February 07, 2025

Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders.

Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders.

Journal: Journal of clinical immunology

Published: June 12, 2024

Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors.

Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors.

Journal: Biomedicines

Published: February 15, 2023

Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression.

Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression.

Journal: Biomedicines

Published: June 04, 2022

Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Journal: Scientific reports

Published: August 14, 2021

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.

A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.

Journal: Blood cells, molecules & diseases

Published: August 31, 2020

Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia.

Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia.

Journal: European journal of haematology

Published: October 08, 2019

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Journal: Scientific reports

Published: August 29, 2019

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.

Use of eltrombopag for secondary immune thrombocytopenia in clinical practice.

Journal: British journal of haematology

Published: January 02, 2017

First case with antithrombin deficiency, mesenteric vein thrombosis and pregnancy: Multidisciplinary diagnosis and successful management.

First case with antithrombin deficiency, mesenteric vein thrombosis and pregnancy: Multidisciplinary diagnosis and successful management.

Journal: Thrombosis research

Published: April 25, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026